| P/E (FY) | — | Sales (TTM) | — |
| Earnings (TTM) | — | ROE | 5.32% |
| Net Margin | 14.04% | ROIC | 4.88% |
| Debt / Equity | 0.28 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms across Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America. Its biosolutions serve food and beverage, bioenergy, household and industrial cleaning, human and animal health, agriculture, grain processing, and textile and leather applications, and include enzyme classes such as lipases, proteases, and carbohydrases. The company is headquartered in Lyngby, Denmark.
| Market Cap | $28.67B | Trading Days | 4087 |
| 52W High | 447.10 |
| 52W Low | 336.80 |
| % Off High | −9.68% |
| YTD | 0.27% | 1Y | −6.61% |
| 3Y | 24.05% | 5Y | −8.11% |
| 10Y | 42.71% | Since incept. (ann.) | 9.48% |
| Ann. Volatility (1Y) | 26.14% | Ann. Volatility (3Y) | 25.40% |
| Sharpe (1Y) | −0.14 | Sharpe (3Y) | 0.46 |
| Max Drawdown (1Y) | −21.89% | Max Drawdown (3Y) | −29.18% |
| Beta (3Y, vs SPY) | 0.50 |
No same-industry peers in the universe for NSIS-B.CO.
